Logo image of CARM.PA

CARMILA (CARM.PA) Stock Fundamental Analysis

EPA:CARM - Euronext Paris - Matif - FR0010828137 - REIT - Currency: EUR

19.16  +0.59 (+3.18%)

Fundamental Rating

6

Overall CARM gets a fundamental rating of 6 out of 10. We evaluated CARM against 42 industry peers in the Diversified REITs industry. CARM has an excellent profitability rating, but there are some minor concerns on its financial health. CARM has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CARM had positive earnings in the past year.
In the past year CARM had a positive cash flow from operations.
CARM had positive earnings in 4 of the past 5 years.
CARM had a positive operating cash flow in each of the past 5 years.
CARM.PA Yearly Net Income VS EBIT VS OCF VS FCFCARM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

The Return On Assets of CARM (4.65%) is better than 78.57% of its industry peers.
With a decent Return On Equity value of 9.19%, CARM is doing good in the industry, outperforming 78.57% of the companies in the same industry.
With a decent Return On Invested Capital value of 4.52%, CARM is doing good in the industry, outperforming 78.57% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CARM is in line with the industry average of 3.74%.
The last Return On Invested Capital (4.52%) for CARM is above the 3 year average (3.52%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.65%
ROE 9.19%
ROIC 4.52%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
CARM.PA Yearly ROA, ROE, ROICCARM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

The Profit Margin of CARM (61.91%) is better than 73.81% of its industry peers.
In the last couple of years the Profit Margin of CARM has grown nicely.
CARM's Operating Margin of 89.71% is amongst the best of the industry. CARM outperforms 88.10% of its industry peers.
In the last couple of years the Operating Margin of CARM has grown nicely.
CARM's Gross Margin of 73.12% is in line compared to the rest of the industry. CARM outperforms 52.38% of its industry peers.
CARM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 89.71%
PM (TTM) 61.91%
GM 73.12%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
CARM.PA Yearly Profit, Operating, Gross MarginsCARM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CARM is destroying value.
Compared to 1 year ago, CARM has less shares outstanding
Compared to 5 years ago, CARM has more shares outstanding
The debt/assets ratio for CARM has been reduced compared to a year ago.
CARM.PA Yearly Shares OutstandingCARM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CARM.PA Yearly Total Debt VS Total AssetsCARM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CARM has an Altman-Z score of 1.00. This is a bad value and indicates that CARM is not financially healthy and even has some risk of bankruptcy.
CARM has a better Altman-Z score (1.00) than 61.90% of its industry peers.
CARM has a debt to FCF ratio of 9.40. This is a negative value and a sign of low solvency as CARM would need 9.40 years to pay back of all of its debts.
CARM has a Debt to FCF ratio of 9.40. This is amongst the best in the industry. CARM outperforms 83.33% of its industry peers.
A Debt/Equity ratio of 0.78 indicates that CARM is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.78, CARM is doing worse than 61.90% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 9.4
Altman-Z 1
ROIC/WACC0.86
WACC5.28%
CARM.PA Yearly LT Debt VS Equity VS FCFCARM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

CARM has a Current Ratio of 1.22. This is a normal value and indicates that CARM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.22, CARM belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
CARM has a Quick Ratio of 1.22. This is a normal value and indicates that CARM is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.22, CARM belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
CARM.PA Yearly Current Assets VS Current LiabilitesCARM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 15358.74% over the past year.
Measured over the past years, CARM shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.86% on average per year.
Looking at the last year, CARM shows a quite strong growth in Revenue. The Revenue has grown by 9.72% in the last year.
The Revenue has been growing slightly by 2.93% on average over the past years.
EPS 1Y (TTM)15358.74%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%815.55%
Revenue 1Y (TTM)9.72%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%19.15%

3.2 Future

Based on estimates for the next years, CARM will show a small growth in Earnings Per Share. The EPS will grow by 4.66% on average per year.
CARM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.05% yearly.
EPS Next Y6.95%
EPS Next 2Y5.63%
EPS Next 3Y4.66%
EPS Next 5YN/A
Revenue Next Year7.01%
Revenue Next 2Y4.75%
Revenue Next 3Y4.05%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CARM.PA Yearly Revenue VS EstimatesCARM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CARM.PA Yearly EPS VS EstimatesCARM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.67, the valuation of CARM can be described as reasonable.
Based on the Price/Earnings ratio, CARM is valued a bit cheaper than the industry average as 78.57% of the companies are valued more expensively.
CARM is valuated cheaply when we compare the Price/Earnings ratio to 28.88, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 10.63, the valuation of CARM can be described as very reasonable.
CARM's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.20, CARM is valued a bit cheaper.
Industry RankSector Rank
PE 8.67
Fwd PE 10.63
CARM.PA Price Earnings VS Forward Price EarningsCARM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CARM is valued cheaper than 85.71% of the companies in the same industry.
73.81% of the companies in the same industry are more expensive than CARM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.25
EV/EBITDA 11.4
CARM.PA Per share dataCARM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CARM may justify a higher PE ratio.
PEG (NY)1.25
PEG (5Y)0.38
EPS Next 2Y5.63%
EPS Next 3Y4.66%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.78%, CARM is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.70, CARM pays a bit more dividend than its industry peers.
CARM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 6.78%

5.2 History

The dividend of CARM decreases each year by -4.29%.
Dividend Growth(5Y)-4.29%
Div Incr Years0
Div Non Decr Years0
CARM.PA Yearly Dividends per shareCARM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

CARM pays out 54.49% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP54.49%
EPS Next 2Y5.63%
EPS Next 3Y4.66%
CARM.PA Yearly Income VS Free CF VS DividendCARM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
CARM.PA Dividend Payout.CARM.PA Dividend Payout, showing the Payout Ratio.CARM.PA Dividend Payout.PayoutRetained Earnings

CARMILA

EPA:CARM (4/30/2025, 7:00:00 PM)

19.16

+0.59 (+3.18%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)04-17 2025-04-17
Earnings (Next)07-23 2025-07-23
Inst Owners31.45%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap2.71B
Analysts81.33
Price Target20.65 (7.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.78%
Yearly Dividend1.21
Dividend Growth(5Y)-4.29%
DP54.49%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.46%
PT rev (3m)5.84%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.02%
EPS NY rev (3m)-0.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.25%
Revenue NY rev (3m)-2.58%
Valuation
Industry RankSector Rank
PE 8.67
Fwd PE 10.63
P/S 5.35
P/FCF 9.25
P/OCF 9.16
P/B 0.79
P/tB 0.8
EV/EBITDA 11.4
EPS(TTM)2.21
EY11.53%
EPS(NY)1.8
Fwd EY9.41%
FCF(TTM)2.07
FCFY10.81%
OCF(TTM)2.09
OCFY10.92%
SpS3.58
BVpS24.11
TBVpS24.1
PEG (NY)1.25
PEG (5Y)0.38
Profitability
Industry RankSector Rank
ROA 4.65%
ROE 9.19%
ROCE 7.04%
ROIC 4.52%
ROICexc 4.63%
ROICexgc 4.63%
OM 89.71%
PM (TTM) 61.91%
GM 73.12%
FCFM 57.84%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
ROICexc(3y)3.79%
ROICexc(5y)3.29%
ROICexgc(3y)3.79%
ROICexgc(5y)3.29%
ROCE(3y)5.48%
ROCE(5y)4.8%
ROICexcg growth 3Y20.72%
ROICexcg growth 5Y9%
ROICexc growth 3Y20.74%
ROICexc growth 5Y9.01%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 9.4
Debt/EBITDA 5.84
Cap/Depr 77.82%
Cap/Sales 0.6%
Interest Coverage 3.75
Cash Conversion 64.59%
Profit Quality 93.43%
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 1
F-Score5
WACC5.28%
ROIC/WACC0.86
Cap/Depr(3y)129.75%
Cap/Depr(5y)102.72%
Cap/Sales(3y)1.8%
Cap/Sales(5y)1.14%
Profit Quality(3y)3321.64%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15358.74%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%815.55%
EPS Next Y6.95%
EPS Next 2Y5.63%
EPS Next 3Y4.66%
EPS Next 5YN/A
Revenue 1Y (TTM)9.72%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%19.15%
Revenue Next Year7.01%
Revenue Next 2Y4.75%
Revenue Next 3Y4.05%
Revenue Next 5YN/A
EBIT growth 1Y57.69%
EBIT growth 3Y24.48%
EBIT growth 5Y10.33%
EBIT Next Year6.66%
EBIT Next 3Y4.28%
EBIT Next 5Y4.34%
FCF growth 1Y8.47%
FCF growth 3Y4.44%
FCF growth 5Y0.82%
OCF growth 1Y7.33%
OCF growth 3Y4.74%
OCF growth 5Y1.02%